Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction notice to "Arabinogalactan derived from Larix gmelinii (Rupr.) Kuzen. Alleviates cisplatin-induced acute intestinal injury in vitro and in vivo through IRE1α/JNK axis mediated apoptotic signaling pathways" [BIOMAC (2022) 871-884].
Zhang JJ, Wang S, Gao XF, Hou YY, Hu JN, Zhang JT, Hou JG, Wang Z, Li X, Li W. Zhang JJ, et al. Among authors: gao xf. Int J Biol Macromol. 2023 Oct 1;250:126273. doi: 10.1016/j.ijbiomac.2023.126273. Epub 2023 Oct 7. Int J Biol Macromol. 2023. PMID: 37813752 No abstract available.
Arabinogalactan derived from Larix gmelinii (Rupr.) Kuzen. Alleviates cisplatin-induced acute intestinal injury in vitro and in vivo through IRE1α/JNK axis mediated apoptotic signaling pathways.
Zhang JJ, Wang S, Gao XF, Hou YY, Hu JN, Zhang JT, Hou JG, Wang Z, Li X, Li W. Zhang JJ, et al. Among authors: gao xf. Int J Biol Macromol. 2022 Jun 1;209(Pt A):871-884. doi: 10.1016/j.ijbiomac.2022.04.068. Epub 2022 Apr 18. Int J Biol Macromol. 2022. PMID: 35439476 Retracted.
Transfemoral transcatheter aortic valve replacement with VitaFlowTM valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial.
Zhang J, Kong XQ, Gao XF, Chen J, Chen X, Li B, Shao YB, Wang Y, Jiang H, Zhu JC, Zhang JJ, Chen SL; SEASON-AR investigators. Zhang J, et al. Among authors: gao xf. Am Heart J. 2024 May;271:76-83. doi: 10.1016/j.ahj.2024.02.022. Epub 2024 Feb 25. Am Heart J. 2024. PMID: 38412895 Clinical Trial.
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
Chen GL, Liu Y, Gao XF, Wu KQ, Yang YK, Chen Y, Peng CG, Jin TH, Huang YB, Zhang YW, Su J, Jiang Q, Guo T, Zhao J, Peng XN, Peng JY, Li SX, Sun YL, Zhang HM, Fu YL, Luo D, Ma Y, Shen ZW, Zhang YT, Shou ZF. Chen GL, et al. Among authors: gao xf. Diabetes Obes Metab. 2024 Apr;26(4):1395-1406. doi: 10.1111/dom.15441. Epub 2024 Jan 29. Diabetes Obes Metab. 2024. PMID: 38287130 Clinical Trial.
285 results